Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmet Dogan

Showing results (301-310 of 371) with videos related to

Pageof 38
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2014
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasmsRaajit Rampal, Jihae Ahn, Omar Abdel-Wahab, et al.
Blood|December 3, 2014
BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphomaCristina Correia, Paula A Schneider, Haiming Dai, et al.
Nature Communications|March 26, 2021
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entitiesBénedith Oben, Guy Froyen, Kylee H Maclachlan, et al.
Blood|October 22, 2024
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutationAnita Kumar, Jacob Soumerai, Jeremy S Abramson, et al.
Blood|May 10, 2024
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myelomaAnthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2026
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in <i>TP53</i>-Mutated Diffuse Large B-Cell LymphomaManik Uppal, Bhavneet Bhinder, Andrew R Marderstein, et al.
Blood Cancer Discovery|January 4, 2021
Revealing the impact of structural variants in multiple myelomaEven H Rustad, Venkata D Yellapantula, Dominik Glodzik, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectPaige M Bracci, Yolanda Benavente, Jennifer J Turner, et al.
Blood|September 2, 2020
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemiaWenbin Xiao, Alexander Chan, Michael R Waarts, et al.
The Journal of Molecular Diagnostics : JMD|March 24, 2023
Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Detailed Description of the Technical Performance, Clinical Utility, and Platform ComparisonKseniya Petrova-Drus, Mustafa Syed, Wayne Yu, et al.
Pageof 38

Showing results (301-310 of 371) with videos related to

Sort By:
Pageof 38
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2014
Genomic and functional analysis of leukemic transformation of myeloproliferative neoplasmsRaajit Rampal, Jihae Ahn, Omar Abdel-Wahab, et al.
Blood|December 3, 2014
BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphomaCristina Correia, Paula A Schneider, Haiming Dai, et al.
Nature Communications|March 26, 2021
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entitiesBénedith Oben, Guy Froyen, Kylee H Maclachlan, et al.
Blood|October 22, 2024
Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutationAnita Kumar, Jacob Soumerai, Jeremy S Abramson, et al.
Blood|May 10, 2024
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myelomaAnthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2026
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in <i>TP53</i>-Mutated Diffuse Large B-Cell LymphomaManik Uppal, Bhavneet Bhinder, Andrew R Marderstein, et al.
Blood Cancer Discovery|January 4, 2021
Revealing the impact of structural variants in multiple myelomaEven H Rustad, Venkata D Yellapantula, Dominik Glodzik, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Medical history, lifestyle, family history, and occupational risk factors for marginal zone lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectPaige M Bracci, Yolanda Benavente, Jennifer J Turner, et al.
Blood|September 2, 2020
Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemiaWenbin Xiao, Alexander Chan, Michael R Waarts, et al.
The Journal of Molecular Diagnostics : JMD|March 24, 2023
Clonal Characterization and Somatic Hypermutation Assessment by Next-Generation Sequencing in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Detailed Description of the Technical Performance, Clinical Utility, and Platform ComparisonKseniya Petrova-Drus, Mustafa Syed, Wayne Yu, et al.
Pageof 38